Filing Details

Accession Number:
0001144204-13-049208
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-04 16:00:31
Reporting Period:
2013-08-30
Filing Date:
2013-09-04
Accepted Time:
2013-09-04 16:00:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235007 Endocyte Inc ECYT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509422 R Allen Ritter 3000 Kent Ave Ste A1-100
West Lafayette IN 47906
Vp Of Manufacturing/Cmc No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-30 6,000 $2.10 23,722 No 4 M Direct
Common Stock Disposition 2013-08-30 6,000 $14.36 17,722 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2013-08-30 6,000 $0.00 6,000 $2.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,560 2017-02-01 No 4 M Direct
Footnotes
  1. This option is fully vested and immediately exercisable.
  2. Represents the sale of 6,000 shares in multiple transactions, ranging in price from $14.26 to $14.45 per share, resulting in a weighted average sale price per share of $14.36. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.